Suzanne George, MD, of Dana-Farber Cancer Institute, discusses current and emerging systemic therapies for soft-tissue sarcoma and the options for multimodality treatment.
Elizabeth R. Plimack, MD, of Fox Chase Canc...
Leo I. Gordon, MD, of the Robert H. Lurie C...
Ruben A. Mesa, MD, of the Mayo Clinic Cance...
David G. Pfister, MD, of Memorial Sloan Ket...
Christina S. Chu, MD, of Fox Chase Cancer C...